世界のFCGR1抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global FCGR1 Antibody Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2326 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、FCGR1抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・FCGR1抗体の市場動向 ・企業の競争状況、市場シェア ・FCGR1抗体の種類別市場規模（95％以上、99％以上、その他） ・FCGR1抗体の用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他） ・FCGR1抗体の北米市場規模2016-2027（アメリカ、カナダ） ・FCGR1抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・FCGR1抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・FCGR1抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・FCGR1抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bio-Rad、Lifespan Biosciences、R&D Systems、Thermo Fisher Scientific、Novus Biologicals、Genetex、Biobyt、Aviva Systems Biology、ProSci、BioLegend、Boster Bio、Abbexa Ltd） ・結論

Market Analysis and Insights: Global FCGR1 Antibody Market
The global FCGR1 Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global FCGR1 Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global FCGR1 Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global FCGR1 Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global FCGR1 Antibody market.

Global FCGR1 Antibody Scope and Market Size
FCGR1 Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global FCGR1 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Above 95%
Above 99%
Others

Segment by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bio-Rad
Lifespan Biosciences
R&D Systems
Thermo Fisher Scientific
Novus Biologicals
Genetex
Biobyt
Aviva Systems Biology
ProSci
Thermo Fisher Scientific

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global FCGR1 Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Above 95%
1.2.3 Above 99%
1.2.4 Others
1.3 Market by Application
1.3.1 Global FCGR1 Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global FCGR1 Antibody Market Perspective (2016-2027)
2.2 FCGR1 Antibody Growth Trends by Regions
2.2.1 FCGR1 Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 FCGR1 Antibody Historic Market Share by Regions (2016-2021)
2.2.3 FCGR1 Antibody Forecasted Market Size by Regions (2022-2027)
2.3 FCGR1 Antibody Industry Dynamic
2.3.1 FCGR1 Antibody Market Trends
2.3.2 FCGR1 Antibody Market Drivers
2.3.3 FCGR1 Antibody Market Challenges
2.3.4 FCGR1 Antibody Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top FCGR1 Antibody Players by Revenue
3.1.1 Global Top FCGR1 Antibody Players by Revenue (2016-2021)
3.1.2 Global FCGR1 Antibody Revenue Market Share by Players (2016-2021)
3.2 Global FCGR1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by FCGR1 Antibody Revenue
3.4 Global FCGR1 Antibody Market Concentration Ratio
3.4.1 Global FCGR1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by FCGR1 Antibody Revenue in 2020
3.5 FCGR1 Antibody Key Players Head office and Area Served
3.6 Key Players FCGR1 Antibody Product Solution and Service
3.7 Date of Enter into FCGR1 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans

4 FCGR1 Antibody Breakdown Data by Type
4.1 Global FCGR1 Antibody Historic Market Size by Type (2016-2021)
4.2 Global FCGR1 Antibody Forecasted Market Size by Type (2022-2027)

5 FCGR1 Antibody Breakdown Data by Application
5.1 Global FCGR1 Antibody Historic Market Size by Application (2016-2021)
5.2 Global FCGR1 Antibody Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America FCGR1 Antibody Market Size (2016-2027)
6.2 North America FCGR1 Antibody Market Size by Type
6.2.1 North America FCGR1 Antibody Market Size by Type (2016-2021)
6.2.2 North America FCGR1 Antibody Market Size by Type (2022-2027)
6.2.3 North America FCGR1 Antibody Market Size by Type (2016-2027)
6.3 North America FCGR1 Antibody Market Size by Application
6.3.1 North America FCGR1 Antibody Market Size by Application (2016-2021)
6.3.2 North America FCGR1 Antibody Market Size by Application (2022-2027)
6.3.3 North America FCGR1 Antibody Market Size by Application (2016-2027)
6.4 North America FCGR1 Antibody Market Size by Country
6.4.1 North America FCGR1 Antibody Market Size by Country (2016-2021)
6.4.2 North America FCGR1 Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe FCGR1 Antibody Market Size (2016-2027)
7.2 Europe FCGR1 Antibody Market Size by Type
7.2.1 Europe FCGR1 Antibody Market Size by Type (2016-2021)
7.2.2 Europe FCGR1 Antibody Market Size by Type (2022-2027)
7.2.3 Europe FCGR1 Antibody Market Size by Type (2016-2027)
7.3 Europe FCGR1 Antibody Market Size by Application
7.3.1 Europe FCGR1 Antibody Market Size by Application (2016-2021)
7.3.2 Europe FCGR1 Antibody Market Size by Application (2022-2027)
7.3.3 Europe FCGR1 Antibody Market Size by Application (2016-2027)
7.4 Europe FCGR1 Antibody Market Size by Country
7.4.1 Europe FCGR1 Antibody Market Size by Country (2016-2021)
7.4.2 Europe FCGR1 Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific FCGR1 Antibody Market Size (2016-2027)
8.2 Asia-Pacific FCGR1 Antibody Market Size by Type
8.2.1 Asia-Pacific FCGR1 Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific FCGR1 Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific FCGR1 Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific FCGR1 Antibody Market Size by Application
8.3.1 Asia-Pacific FCGR1 Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific FCGR1 Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific FCGR1 Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific FCGR1 Antibody Market Size by Region
8.4.1 Asia-Pacific FCGR1 Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific FCGR1 Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America FCGR1 Antibody Market Size (2016-2027)
9.2 Latin America FCGR1 Antibody Market Size by Type
9.2.1 Latin America FCGR1 Antibody Market Size by Type (2016-2021)
9.2.2 Latin America FCGR1 Antibody Market Size by Type (2022-2027)
9.2.3 Latin America FCGR1 Antibody Market Size by Type (2016-2027)
9.3 Latin America FCGR1 Antibody Market Size by Application
9.3.1 Latin America FCGR1 Antibody Market Size by Application (2016-2021)
9.3.2 Latin America FCGR1 Antibody Market Size by Application (2022-2027)
9.3.3 Latin America FCGR1 Antibody Market Size by Application (2016-2027)
9.4 Latin America FCGR1 Antibody Market Size by Country
9.4.1 Latin America FCGR1 Antibody Market Size by Country (2016-2021)
9.4.2 Latin America FCGR1 Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa FCGR1 Antibody Market Size (2016-2027)
10.2 Middle East & Africa FCGR1 Antibody Market Size by Type
10.2.1 Middle East & Africa FCGR1 Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa FCGR1 Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa FCGR1 Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa FCGR1 Antibody Market Size by Application
10.3.1 Middle East & Africa FCGR1 Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa FCGR1 Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa FCGR1 Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa FCGR1 Antibody Market Size by Country
10.4.1 Middle East & Africa FCGR1 Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa FCGR1 Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad FCGR1 Antibody Introduction
11.1.4 Bio-Rad Revenue in FCGR1 Antibody Business (2016-2021)
11.1.5 Bio-Rad Recent Development
11.2 Lifespan Biosciences
11.2.1 Lifespan Biosciences Company Details
11.2.2 Lifespan Biosciences Business Overview
11.2.3 Lifespan Biosciences FCGR1 Antibody Introduction
11.2.4 Lifespan Biosciences Revenue in FCGR1 Antibody Business (2016-2021)
11.2.5 Lifespan Biosciences Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Details
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems FCGR1 Antibody Introduction
11.3.4 R&D Systems Revenue in FCGR1 Antibody Business (2016-2021)
11.3.5 R&D Systems Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific FCGR1 Antibody Introduction
11.4.4 Thermo Fisher Scientific Revenue in FCGR1 Antibody Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Novus Biologicals
11.5.1 Novus Biologicals Company Details
11.5.2 Novus Biologicals Business Overview
11.5.3 Novus Biologicals FCGR1 Antibody Introduction
11.5.4 Novus Biologicals Revenue in FCGR1 Antibody Business (2016-2021)
11.5.5 Novus Biologicals Recent Development
11.6 Genetex
11.6.1 Genetex Company Details
11.6.2 Genetex Business Overview
11.6.3 Genetex FCGR1 Antibody Introduction
11.6.4 Genetex Revenue in FCGR1 Antibody Business (2016-2021)
11.6.5 Genetex Recent Development
11.7 Biobyt
11.7.1 Biobyt Company Details
11.7.2 Biobyt Business Overview
11.7.3 Biobyt FCGR1 Antibody Introduction
11.7.4 Biobyt Revenue in FCGR1 Antibody Business (2016-2021)
11.7.5 Biobyt Recent Development
11.8 Aviva Systems Biology
11.8.1 Aviva Systems Biology Company Details
11.8.2 Aviva Systems Biology Business Overview
11.8.3 Aviva Systems Biology FCGR1 Antibody Introduction
11.8.4 Aviva Systems Biology Revenue in FCGR1 Antibody Business (2016-2021)
11.8.5 Aviva Systems Biology Recent Development
11.9 ProSci
11.9.1 ProSci Company Details
11.9.2 ProSci Business Overview
11.9.3 ProSci FCGR1 Antibody Introduction
11.9.4 ProSci Revenue in FCGR1 Antibody Business (2016-2021)
11.9.5 ProSci Recent Development
11.10 BioLegend
11.10.1 BioLegend Company Details
11.10.2 BioLegend Business Overview
11.10.3 BioLegend FCGR1 Antibody Introduction
11.10.4 BioLegend Revenue in FCGR1 Antibody Business (2016-2021)
11.10.5 BioLegend Recent Development
11.11 Boster Bio
11.11.1 Boster Bio Company Details
11.11.2 Boster Bio Business Overview
11.11.3 Boster Bio FCGR1 Antibody Introduction
11.11.4 Boster Bio Revenue in FCGR1 Antibody Business (2016-2021)
11.11.5 Boster Bio Recent Development
11.12 Abbexa Ltd
11.12.1 Abbexa Ltd Company Details
11.12.2 Abbexa Ltd Business Overview
11.12.3 Abbexa Ltd FCGR1 Antibody Introduction
11.12.4 Abbexa Ltd Revenue in FCGR1 Antibody Business (2016-2021)
11.12.5 Abbexa Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global FCGR1 Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Above 95%
Table 3. Key Players of Above 99%
Table 4. Key Players of Others
Table 5. Global FCGR1 Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global FCGR1 Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global FCGR1 Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global FCGR1 Antibody Market Share by Regions (2016-2021)
Table 9. Global FCGR1 Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global FCGR1 Antibody Market Share by Regions (2022-2027)
Table 11. FCGR1 Antibody Market Trends
Table 12. FCGR1 Antibody Market Drivers
Table 13. FCGR1 Antibody Market Challenges
Table 14. FCGR1 Antibody Market Restraints
Table 15. Global FCGR1 Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global FCGR1 Antibody Market Share by Players (2016-2021)
Table 17. Global Top FCGR1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in FCGR1 Antibody as of 2020)
Table 18. Ranking of Global Top FCGR1 Antibody Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by FCGR1 Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players FCGR1 Antibody Product Solution and Service
Table 22. Date of Enter into FCGR1 Antibody Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global FCGR1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 25. Global FCGR1 Antibody Revenue Market Share by Type (2016-2021)
Table 26. Global FCGR1 Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global FCGR1 Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global FCGR1 Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global FCGR1 Antibody Revenue Market Share by Application (2016-2021)
Table 30. Global FCGR1 Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global FCGR1 Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America FCGR1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 33. North America FCGR1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America FCGR1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 35. North America FCGR1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America FCGR1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America FCGR1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe FCGR1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe FCGR1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe FCGR1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe FCGR1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe FCGR1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe FCGR1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific FCGR1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific FCGR1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific FCGR1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific FCGR1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific FCGR1 Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific FCGR1 Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America FCGR1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America FCGR1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America FCGR1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America FCGR1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America FCGR1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America FCGR1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa FCGR1 Antibody Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa FCGR1 Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa FCGR1 Antibody Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa FCGR1 Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa FCGR1 Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa FCGR1 Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bio-Rad Company Details
Table 63. Bio-Rad Business Overview
Table 64. Bio-Rad FCGR1 Antibody Product
Table 65. Bio-Rad Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 66. Bio-Rad Recent Development
Table 67. Lifespan Biosciences Company Details
Table 68. Lifespan Biosciences Business Overview
Table 69. Lifespan Biosciences FCGR1 Antibody Product
Table 70. Lifespan Biosciences Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 71. Lifespan Biosciences Recent Development
Table 72. R&D Systems Company Details
Table 73. R&D Systems Business Overview
Table 74. R&D Systems FCGR1 Antibody Product
Table 75. R&D Systems Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 76. R&D Systems Recent Development
Table 77. Thermo Fisher Scientific Company Details
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific FCGR1 Antibody Product
Table 80. Thermo Fisher Scientific Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Novus Biologicals Company Details
Table 83. Novus Biologicals Business Overview
Table 84. Novus Biologicals FCGR1 Antibody Product
Table 85. Novus Biologicals Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 86. Novus Biologicals Recent Development
Table 87. Genetex Company Details
Table 88. Genetex Business Overview
Table 89. Genetex FCGR1 Antibody Product
Table 90. Genetex Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 91. Genetex Recent Development
Table 92. Biobyt Company Details
Table 93. Biobyt Business Overview
Table 94. Biobyt FCGR1 Antibody Product
Table 95. Biobyt Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 96. Biobyt Recent Development
Table 97. Aviva Systems Biology Company Details
Table 98. Aviva Systems Biology Business Overview
Table 99. Aviva Systems Biology Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 100. Aviva Systems Biology Recent Development
Table 101. ProSci Company Details
Table 102. ProSci Business Overview
Table 103. ProSci FCGR1 Antibody Product
Table 104. ProSci Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 105. ProSci Recent Development
Table 106. BioLegend Company Details
Table 107. BioLegend Business Overview
Table 108. BioLegend FCGR1 Antibody Product
Table 109. BioLegend Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 110. BioLegend Recent Development
Table 111. Boster Bio Company Details
Table 112. Boster Bio Business Overview
Table 113. Boster Bio FCGR1 Antibody Product
Table 114. Boster Bio Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 115. Boster Bio Recent Development
Table 116. Abbexa Ltd Company Details
Table 117. Abbexa Ltd Business Overview
Table 118. Abbexa Ltd FCGR1 Antibody Product
Table 119. Abbexa Ltd Revenue in FCGR1 Antibody Business (2016-2021) & (US$ Million)
Table 120. Abbexa Ltd Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global FCGR1 Antibody Market Share by Type: 2020 VS 2027
Figure 2. Above 95% Features
Figure 3. Above 99% Features
Figure 4. Others Features
Figure 5. Global FCGR1 Antibody Market Share by Application: 2020 VS 2027
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Bioscience Research Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. FCGR1 Antibody Report Years Considered
Figure 11. Global FCGR1 Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global FCGR1 Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global FCGR1 Antibody Market Share by Regions: 2020 VS 2027
Figure 14. Global FCGR1 Antibody Market Share by Regions (2022-2027)
Figure 15. Global FCGR1 Antibody Market Share by Players in 2020
Figure 16. Global Top FCGR1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in FCGR1 Antibody as of 2020
Figure 17. The Top 10 and 5 Players Market Share by FCGR1 Antibody Revenue in 2020
Figure 18. Global FCGR1 Antibody Revenue Market Share by Type (2016-2021)
Figure 19. Global FCGR1 Antibody Revenue Market Share by Type (2022-2027)
Figure 20. North America FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America FCGR1 Antibody Market Share by Type (2016-2027)
Figure 22. North America FCGR1 Antibody Market Share by Application (2016-2027)
Figure 23. North America FCGR1 Antibody Market Share by Country (2016-2027)
Figure 24. United States FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe FCGR1 Antibody Market Share by Type (2016-2027)
Figure 28. Europe FCGR1 Antibody Market Share by Application (2016-2027)
Figure 29. Europe FCGR1 Antibody Market Share by Country (2016-2027)
Figure 30. Germany FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific FCGR1 Antibody Market Share by Type (2016-2027)
Figure 38. Asia-Pacific FCGR1 Antibody Market Share by Application (2016-2027)
Figure 39. Asia-Pacific FCGR1 Antibody Market Share by Region (2016-2027)
Figure 40. China FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America FCGR1 Antibody Market Share by Type (2016-2027)
Figure 48. Latin America FCGR1 Antibody Market Share by Application (2016-2027)
Figure 49. Latin America FCGR1 Antibody Market Share by Country (2016-2027)
Figure 50. Mexico FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa FCGR1 Antibody Market Share by Type (2016-2027)
Figure 54. Middle East & Africa FCGR1 Antibody Market Share by Application (2016-2027)
Figure 55. Middle East & Africa FCGR1 Antibody Market Share by Country (2016-2027)
Figure 56. Turkey FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE FCGR1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bio-Rad Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 60. Lifespan Biosciences Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 61. R&D Systems Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 63. Novus Biologicals Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 64. Genetex Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 65. Biobyt Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 66. Aviva Systems Biology Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 67. ProSci Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 68. BioLegend Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 69. Boster Bio Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 70. Abbexa Ltd Revenue Growth Rate in FCGR1 Antibody Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---